• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Dextran and deferoxamine
Date Designated: 03/08/1991
Orphan Designation: Treatment of acute iron poisoning.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Biomedical Frontiers, Inc.
1095 10th Avenue S.E.
Minneapolis, Minnesota 55414
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-